Literature DB >> 1095494

Prolonging morbidity in rabid dogs by intrathecal injection of attenuated rabies vaccine.

G M Baer, J H Shaddock, L W Williams.   

Abstract

Dogs vaccinated intrathecally with attenuated rabies vaccine developed antibodies that were detected in the cerebrospinal fluid, blood, and brain; dogs similarly vaccinated but with an inactivated vaccine developed no antibodies in the brain. When the attenuated vaccine was administered to rabid dogs, a prolongation of the morbidity period was noted and, in some dogs, recovery from the disease. Rhesus monkeys died when administered any of the available attenuated vaccines intrathecally, and further studies with that species could not be undertaken.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1095494      PMCID: PMC415251          DOI: 10.1128/iai.12.1.98-103.1975

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  Fluorescent antibody staining of street and fixed rabies virus antigens.

Authors:  R A GOLDWASSER; R E KISSLING
Journal:  Proc Soc Exp Biol Med       Date:  1958-06

2.  Biological modification of rabies virus as a result of its adaptation to chicks and developing chick embryos.

Authors:  H KOPROWSKI
Journal:  Bull World Health Organ       Date:  1954       Impact factor: 9.408

3.  An Attenuated Rabies Vaccine for Domestic Animals Produced in Tissue Culture.

Authors:  M K Abelseth
Journal:  Can Vet J       Date:  1964-11       Impact factor: 1.008

4.  Polyoma transformation of hamster cell clones--an investigation of genetic factors affecting cell competence.

Authors:  I MACPHERSON; M STOKER
Journal:  Virology       Date:  1962-02       Impact factor: 3.616

5.  A case of human rabies with prolonged survival.

Authors:  R W Emmons; L L Leonard; F DeGenaro; E S Protas; P L Bazeley; S T Giammona; K Sturckow
Journal:  Intervirology       Date:  1973       Impact factor: 1.763

6.  Local antibody response to experimental poliovirus infection in the central nervous system of rhesus monkeys.

Authors:  P L Ogra; S S Ogra; S al-Nakeeb; P R Coppola
Journal:  Infect Immun       Date:  1973-12       Impact factor: 3.441

7.  Nonfatal canine rabies.

Authors:  R J Arko; L G Schneider; G M Baer
Journal:  Am J Vet Res       Date:  1973-07       Impact factor: 1.156

8.  Recovery from rabies. A case report.

Authors:  M A Hattwick; T T Weis; C J Stechschulte; G M Baer; M B Gregg
Journal:  Ann Intern Med       Date:  1972-06       Impact factor: 25.391

9.  Characterization of brain-associated rabies neutralizing substance.

Authors:  P M Gough; R E Dierks; R M Russell; B G Archer
Journal:  J Infect Dis       Date:  1974-04       Impact factor: 5.226

10.  Laboratory techniques in rabies: the mouse inoculation test.

Authors:  H Koprowski
Journal:  Monogr Ser World Health Organ       Date:  1973
View more
  9 in total

Review 1.  Experimental rabies vaccines for humans.

Authors:  James P McGettigan
Journal:  Expert Rev Vaccines       Date:  2010-10       Impact factor: 5.217

2.  An attempt to treat rabies encephalitis in monkeys with intrathecal live rabies virus RV 675. Brief report.

Authors:  M J Warrell; G S Ward; M R Elwell; M Tingpalapong
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

3.  Therapeutic immune clearance of rabies virus from the CNS.

Authors:  D Craig Hooper; Anirban Roy; Rhonda B Kean; Timothy W Phares; Darryll A Barkhouse
Journal:  Future Virol       Date:  2011-03-01       Impact factor: 1.831

4.  Pre- and post-exposure safety and efficacy of attenuated rabies virus vaccines are enhanced by their expression of IFNγ.

Authors:  Darryll A Barkhouse; Milosz Faber; D Craig Hooper
Journal:  Virology       Date:  2014-11-19       Impact factor: 3.616

5.  Expression of interferon gamma by a recombinant rabies virus strongly attenuates the pathogenicity of the virus via induction of type I interferon.

Authors:  Darryll A Barkhouse; Samantha A Garcia; Emily K Bongiorno; Aurore Lebrun; Milosz Faber; D Craig Hooper
Journal:  J Virol       Date:  2014-10-15       Impact factor: 5.103

6.  Failure of interferon alfa and tribavirin in rabies encephalitis.

Authors:  M J Warrell; N J White; S Looareesuwan; R E Phillips; P Suntharasamai; P Chanthavanich; M Riganti; S P Fisher-Hoch; K G Nicholson; S Manatsathit
Journal:  BMJ       Date:  1989-09-30

7.  Differential Host Immune Responses after Infection with Wild-Type or Lab-Attenuated Rabies Viruses in Dogs.

Authors:  Clement W Gnanadurai; Yang Yang; Ying Huang; Zhenguang Li; Christina M Leyson; Tanya L Cooper; Simon R Platt; Stephen B Harvey; Douglas C Hooper; Milosz Faber; Zhen F Fu
Journal:  PLoS Negl Trop Dis       Date:  2015-08-20

8.  Novel Approaches to the Prevention and Treatment of Rabies.

Authors:  C W Gnanadurai; C T Huang; D Kumar; Zhen F Fu
Journal:  Int J Virol Stud Res       Date:  2015-04-07

Review 9.  The Imperative of Palliation in the Management of Rabies Encephalomyelitis.

Authors:  Mary Warrell; David A Warrell; Arnaud Tarantola
Journal:  Trop Med Infect Dis       Date:  2017-10-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.